C1q anticorps (FITC)
Aperçu rapide pour C1q anticorps (FITC) (ABIN2477784)
Antigène
Voir toutes C1q AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
-
Immunogène
- Human C1q, purified from plasma
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 10 mg/mL
-
-
-
: "Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." dans: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
: "Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents." dans: Blood, Vol. 103, Issue 7, pp. 2738-43, (2004) (PubMed).
: "Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity." dans: Journal of neuroimmunology, Vol. 137, Issue 1-2, pp. 12-8, (2003) (PubMed).
-
: "Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." dans: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
-
-